The role of occlusion in corticosteroid therapy of psoriasis

References

• Sulzberger M B, Witten V N. Thin pliable plastic films in topical dermatologic therapy. Arch Dermatol 1961; 84: 1027
   PubMed Web of Science ®Google Scholar
• Fry L, Almeyda J, McMinn R MH. Effect of plastic occlusive dressings on psoriatic epidermis. Br J Dermatol 1970; 82: 458–62
   PubMedGoogle Scholar
• Baxter D L, Stoughton R B. Mitotic index of psoriatic lesions treated with anthralin, glucocorticosteroid and occlusion only. J Invest Dermatol 1970; 54: 410–12
   PubMed Web of Science ®Google Scholar
• Fisher L B, Maibach H I. Physical occlusion controlling epidermal mitosis. J Invest Dermatol 1972; 59: 106–8
   PubMedGoogle Scholar
• Shore R N. Clearing of psoriatic lesions after the application of tape. N Engl J Med 1985; 312: 246
   PubMedGoogle Scholar
• Friedman S J. Management of psoriasis vulgaris with a hydrocolloid occlusive dressing. Arch Dermatol 1987; 123: 1046–52
   PubMed Web of Science ®Google Scholar
• McKenzie A W, Stoughton R B. Method for comparing percutaneous absorption of steroids. Arch Dermatol 1962; 86: 608
   Web of Science ®Google Scholar
• Feldman R J, Maibach H I. Penetration of 14C hydrocortisone through normal skin. The effect of stripping and occlusion. Arch Dermatol 1965; 19: 661–6
   Google Scholar
• Griffith W AD, Wilkinson J D. Topical therapy. Rook/Wilkinson/Ebling Textbook of Dermatology, R H Champion, J L Burton, F JG Ebling. Blackwell Scientific Publications, Oxford 1992; 3037–84
   Google Scholar
• David M, Lowe N J. Psoriasis therapy: comparative studies with a hydrocolloid dressing, plastic film occlusion, and triamcinolone acetonide cream. J Am Acad Dermatol 1989; 21: 511–14
   PubMed Web of Science ®Google Scholar
• Juhlin L. Treatment of psoriasis and other dermatoses with a single application of a corticosteroid left under a hydrocolloid dressing for one-week. Acta Derm Venereol (Stockh) 1989; 69: 355–7
   PubMed Web of Science ®Google Scholar
• Wilkinson R D, Ohayon M. Therapeutic response to a dermatologic patch and betamethasone valerate 0.1 percent cream in the management of chronic plaques in psoriasis. Cutis 1990; 45: 468–70
   PubMedGoogle Scholar
• The Actiderm Multi-Center Study Group. A trial of the actiderm dermatological patch and topical corticosteroids in the treatment of psoriasis vulgaris. Cutis 1990; 46: 84–8
   PubMedGoogle Scholar
• Kragballe K, Larsen G F. A hydrocolloid occlusive dressing plus triamcinolone acetonide cream is superior to clobetasol cream in palmo-plantar pustulosis. Acta Derm Venereol (Stockh) 1991; 71: 540–2
   PubMed Web of Science ®Google Scholar
• Volden G. Successful treatment of chronic skin diseases with clobetasol propionate and a hydrocolloid occlusive dressing. Acta Derm Venereol (Stockh) 1992; 72: 69–71
   PubMed Web of Science ®Google Scholar
• Van de Kerkhof P CM, et al. Weekly treatment of psoriasis with a hydrocolloid dressing in combination with triamcinolone acetonide. Acta Derm Venereol (Stockh) 1994; 74: 143–6
   PubMedGoogle Scholar
• Griffiths C EM, Tranfaglia M G, Kang S. Prolonged occlusion in the treatment of psoriasis: a clinical and immunohistologic study. J Am Acad Dermatol 1995; 32: 618–22
   PubMed Web of Science ®Google Scholar
• Broby-Johansen U, Kristensen J K. Antipsoriatic effect of local corticosteroids – O2-consumption and blood flow measurements compared to clinical parameters. Clin Exp Dermatol 1989; 14: 137–40
   PubMedGoogle Scholar
• Broby-Johansen U, et al. Ranking of the antipsoriatic effect of various topical corticosteroids applied under a hydrocolloid dressing – skin-thickness, blood-flow and colour measurement compared to clinical assessment. Clin Exp Dermatol 1990; 15: 343–8
   PubMedGoogle Scholar
• Halprin K M, Fukui K, Ohkawara A. Fluradrenolone (Cordran) tape and carbohydrate metabolizing enzymes. Arch Dermatol 1969; 100: 336–41
   PubMedGoogle Scholar
• Urabe H, Nishitani K, Kohda H. Hyperthermia in the treatment of psoriasis. Arch Dermatol 1981; 117: 770–4
   PubMedGoogle Scholar
• Orenberg E K, Deneau D G, Farber E M. Response of chronic psoriatic plaques to localized heating induced by ultrasound. Arch Dermatol 1980; 116: 893–7
   PubMedGoogle Scholar
• Gottlieb A B, et al. Occlusive hydrocolloid dressings decrease keratinocyte population growth fraction and clinical scale and skin thickness in active psoriatic plaques. J Dermatol Sci 1990; 1: 93–6
   PubMedGoogle Scholar
• Van Vlijmen-Willems I MJJ, et al. The immunohistochemical effect of a hydrocolloid occlusive dressing (duoDERM E) in psoriasis vulgaris. Dermatology 1993; 187: 257–62
   PubMedGoogle Scholar
• Lotti T. Occlusive treatment in psoriasis: how does it work?. J Am Acad Dermatol 1996; 35: 283
   PubMedGoogle Scholar
• Grubauer G, Elias P M, Feingold K R. Transepidermal water loss: the signal for recovery of barrier structure and function. J Lipid Res 1989; 30: 323–33
   PubMed Web of Science ®Google Scholar
• Proksch E, et al. Barrier function regulates epidermal DNA synthesis. J Clin Invest 1991; 87: 1668–73
   PubMed Web of Science ®Google Scholar
• Wood L C, et al. Barrier disruption stimulates interleukin-1 α expression and release from a pre-formed pool in murine epidermis. J Invest Dermatol 1996; 106: 397–403
   PubMed Web of Science ®Google Scholar
• Proksch E, Brasch J, Sterry W. Integrity of the permeability barrier regulates epidermal Langerhans cell density. Br J Dermatol 1996; 134: 630–8
   Google Scholar